In this interview, News-Medical talks to Dr. Klaus Lun and Chris Mason about the past, present and future of automation and digitalization in the life sciences laboratory and especially the impact this could have on next-generation sequencing and genomics.
Cannabist Pays Down $25 Million of Debt
The Cannabist Company Announces Partial Redemption of 13% Senior Secured Notes Due May 2024 NEW YORK–(BUSINESS WIRE), October 9, 2023–The Cannabist Company Holdings Inc. (NEO: